Chronic Calcific Pancreatitis in a 9-Year-Old Boy
Journal Title: Journal of Enam Meical College - Year 2012, Vol 2, Issue 1
Abstract
Chronic pancreatitis is defined as continuing inflammatory disease of pancreas, characterised by irreversible morphological changes leading to pancreatic insufficiency. Chronic pancreatic insufficiency without pancreatitis is also seen in children suffering from cystic fibrosis which is a disease with congenital enzyme deficiency. Mean age of chronic pancreatitis is about 40 years. We present a case of a 9-year-old boy who was diagnosed as a case of chronic calcific pancreatitis. He was admitted with the complaints of paraumbilical pain and vomiting and was found diabetic. Diagnosis was established by X-ray, USG and CT scan of abdomen and ERCP. He was treated surgically in the form of lateral pancreaticojejunostomy (Puestow’s procedure).
Authors and Affiliations
Debasish Das, Dev Prosad Paul, Kazi Sohel Iqbal
Keywords
Related Articles
- EP ID EP36143
- DOI https://doi.org/10.3329/jemc.v2i1.11929
- Views 321
- Downloads 0
Unusual Foreign Bodies in the Lower Genitourinary Tract
Foreign body in the lower genitourinary tract is a relatively rare occurrence. A variety of foreign bodies have been reported in the literature. Commonly reported condition under which foreign bodies are introduced int...
A 50-Year-Old Male with Dapsone Hypersensitivity Syndrome
Dapsone, diamino-diphenyl sulfone, is an antibacterial and anti-inflammatory drug which is used worldwide for treating many diseases, such as leprosy, dermatitis herpetiformis, linear IgA bullous dermatosis, chronic bul...
Medical Biotechnology: Problems and Prospects in Bangladesh
Biotechnology is the knowledge and techniques of developing and using biological systems for deriving special products and services. The age-old technology took a new turn with the advent of recombinant DNA techniques, a...
Tobacco: The Silent Killer
No Abstract
Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis
Sulfasalazine is a well-established disease-modifying agent. It is commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. The most frequently reported adverse effects are gastrointestinal...